FilingSEC EDGAR8-K
Annovis Bio Announces $21.0 Million Public Offering
· SEC accepted
StagePhase 3
Filing content
Annovis Bio is conducting a public offering of common stock and warrants for approximately $21.0 million, with proceeds intended for clinical development and working capital.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…